Donna Roy Grogan is Director of C4 Therapeutics, Inc.. Currently has a direct ownership of 28,942 shares of CCCC, which is worth approximately $116,057. The most recent transaction as insider was on Oct 01, 2024, when has been sold 2,474 shares (Common Stock) at a price of $5.56 per share, resulting in proceeds of $13,755. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.9K
9.35% 3M change
45.97% 12M change
Total Value Held $116,057

DONNA ROY GROGAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
BUY
Grant, award, or other acquisition
$13,755 $5.56 p/Share
2,474 Added 7.87%
28,942 Common Stock
Jul 01 2024
BUY
Grant, award, or other acquisition
$13,754 $4.85 p/Share
2,836 Added 9.68%
26,468 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
$13,745 $8.1 p/Share
1,697 Added 6.7%
23,632 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
$13,744 $6.52 p/Share
2,108 Added 8.77%
21,935 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
$13,751 $1.7 p/Share
8,089 Added 28.98%
19,827 Common Stock
Jul 03 2023
BUY
Grant, award, or other acquisition
$13,748 $2.83 p/Share
4,858 Added 29.27%
11,738 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
$13,753 $3.2 p/Share
4,298 Added 38.45%
6,880 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
$11,247 $6.38 p/Share
1,763 Added 40.58%
2,582 Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
$7,117 $8.69 p/Share
819 Added 50.0%
819 Common Stock
DRG

Donna Roy Grogan

Director
Watertown, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC